LHX3 Interacts with Inhibitor of Histone Acetyltransferase Complex Subunits LANP and TAF-1β to Modulate Pituitary Gene Regulation

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Hunter, Chad S ^a,c   Malik, Raleigh E ^b   Witzmann, Frank A ^b   Rhodes, Simon J ^a,b  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN LANP; PROTEIN TAF 1BETA; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR LHX3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHROMATIN STRUCTURE; CONTROLLED STUDY; EMBRYO; GENE CONTROL; GENETIC TRANSCRIPTION; HISTONE ACETYLATION; HUMAN; HUMAN CELL; HYPOPHYSIS; HYPOPHYSIS CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION;

ACETYLATION; ANIMALS; BINDING SITES; CELL LINE; CHROMATIN; GENE EXPRESSION REGULATION; GENES, REPORTER; HEK293 CELLS; HISTONE ACETYLTRANSFERASES; HISTONES; HUMANS; LIM-HOMEODOMAIN PROTEINS; LUCIFERASES; MICE; PITUITARY GLAND; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEIN SUBUNITS; SIGNAL TRANSDUCTION; TATA-BINDING PROTEIN ASSOCIATED FACTORS; TRANSCRIPTION FACTOR TFIID; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

ANIMALIA; MAMMALIA;

EID: 84879819300     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068898     Document Type: Article

References (68)

1. Hunter CS, Rhodes SJ, (2005) LIM-homeodomain genes in mammalian development and human disease. Mol Biol Rep 32: 67-77.
2. Bach I, (2000) The LIM domain: regulation by association. Mech Dev 91: 5-17.
3. Bridwell JA, Price JR, Parker GE, McCutchan Schiller A, Sloop KW, et al. (2001) Role of the LIM domains in DNA recognition by the Lhx3 neuroendocrine transcription factor. Gene 277: 239-250.
4. Banerjee-Basu S, Baxevanis AD, (2001) Molecular evolution of the homeodomain family of transcription factors. Nucleic acids research 29: 3258-3269.
5. Kelberman D, Rizzoti K, Lovell-Badge R, Robinson IC, Dattani MT, (2009) Genetic regulation of pituitary gland development in human and mouse. Endocr Rev 30: 790-829.
6. Davis SW, Castinetti F, Carvalho LR, Ellsworth BS, Potok MA, et al. (2010) Molecular mechanisms of pituitary organogenesis: In search of novel regulatory genes. Molecular and Cellular Endocrinology 323: 4-19.
7. Mollard P, Hodson DJ, Lafont C, Rizzoti K, Drouin J, (2012) A tridimensional view of pituitary development and function. Trends Endocrinol Metab 23: 261-269.
8. Prince KL, Walvoord EC, Rhodes SJ, (2011) The role of homeodomain transcription factors in heritable pituitary disease. Nat Rev Endocrinol 7: 727-737.
9. Sheng HZ, Moriyama K, Yamashita T, Li H, Potter SS, et al. (1997) Multistep control of pituitary organogenesis. Science 278: 1809-1812.
10. Sheng HZ, Zhadanov AB, Mosinger B Jr, Fujii T, Bertuzzi S, et al. (1996) Specification of pituitary cell lineages by the LIM homeobox gene Lhx3. Science 272: 1004-1007.
11. Sharma K, Sheng HZ, Lettieri K, Li H, Karavanov A, et al. (1998) LIM homeodomain factors Lhx3 and Lhx4 assign subtype identities for motor neurons. Cell 95: 817-828.
12. Bach I, Rhodes SJ, Pearse RV, 2nd, Heinzel T, Gloss B, et al (1995) P-Lim, a LIM homeodomain factor, is expressed during pituitary organ and cell commitment and synergizes with Pit-1. Proc Natl Acad Sci U S A 92: 2720-2724.
13. Zhadanov AB, Bertuzzi S, Taira M, Dawid IB, Westphal H, (1995) Expression pattern of the murine LIM class homeobox gene Lhx3 in subsets of neural and neuroendocrine tissues. Dev Dynam 202: 354-364.
14. Seidah NG, Barale JC, Marcinkiewicz M, Mattei MG, Day R, et al. (1994) The mouse homeoprotein mLIM-3 is expressed early in cells derived from the neuroepithelium and persists in adult pituitary. DNA Cell Biol 13: 1163-1180.
15. Bhangoo AP, Hunter CS, Savage JJ, Anhalt H, Pavlakis S, et al. (2006) Clinical case seminar: a novel LHX3 mutation presenting as combined pituitary hormonal deficiency. J Clin Endocrinol Metab 91: 747-753.
16. Bonfig W, Krude H, Schmidt H (2011) A novel mutation of LHX3 is associated with combined pituitary hormone deficiency including ACTH deficiency, sensorineural hearing loss, and short neck-a case report and review of the literature. Eur J Pediatr.
17. Kriström B, Zdunek A-M, Rydh A, Jonsson H, Sehlin P, et al. (2009) A novel mutation in the LHX3 gene is responsible for combined pituitary hormone deficiency, hearing impairment and vertebral malformations. J Clin Endocrinol Metabol 94: 1154-1161.
18. Netchine I, Sobrier ML, Krude H, Schnabel D, Maghnie M, et al. (2000) Mutations in LHX3 result in a new syndrome revealed by combined pituitary hormone deficiency. Nat Genet 25: 182-186.
19. Pfaeffle RW, Savage JJ, Hunter CS, Palme C, Ahlmann M, et al. (2007) Four novel mutations of the LHX3 gene cause combined pituitary hormone deficiencies with or without limited neck rotation. J Clin Endocrinol Metab 92: 1909-1919.
20. Rajab A, Kelberman D, de Castro SC, Biebermann H, Shaikh H, et al. (2008) Novel mutations in LHX3 are associated with hypopituitarism and sensorineural hearing loss. Hum Mol Genet 17: 2150-2159.
21. Savage JJ, Hunter CS, Clark-Sturm SL, Jacob TM, Pfaeffle RW, et al. (2007) Mutations in the LHX3 gene cause dysregulation of pituitary and neural target genes that reflect patient phenotypes. Gene 400: 44-51.
22. Bechtold-Dalla Pozza S, Hiedl S, Roeb J, Lohse P, Malik RE, et al. (2012) A recessive mutation resulting in a disabling amino acid substitution (T194R) in the LHX3 homeodomain causes combined pituitary hormone deficiency. Horm Res Paediatr 77: 41-51.
23. Sobrier ML, Brachet C, Vie-Luton MP, Perez C, Copin B, et al. (2012) Symptomatic heterozygotes and prenatal diagnoses in a nonconsanguineous family with syndromic combined pituitary hormone deficiency resulting from two novel LHX3 mutations. J Clin Endocrinol Metab 97: E503-509.
24. Colvin SC, Malik RE, Showalter AD, Sloop KW, Rhodes SJ, (2011) Model of pediatric pituitary hormone deficiency separates the endocrine and neural functions of the LHX3 transcription factor in vivo. Proc Natl Acad Sci U S A 108: 173-178.
25. Prince KL, Colvin SC, Park S, Lai X, Witzmann FA, et al. (2013) Developmental analysis and influence of genetic background on the Lhx3 W227ter mouse model of combined pituitary hormone deficiency disease. Endocrinology 154: 738-748.
26. Thaler JP, Lee SK, Jurata LW, Gill GN, Pfaff SL, (2002) LIM factor Lhx3 contributes to the specification of motor neuron and interneuron identity through cell-type-specific protein-protein interactions. Cell 110: 237-249.
27. Thor S, Andersson SG, Tomlinson A, Thomas JB, (1999) A LIM-homeodomain combinatorial code for motor-neuron pathway selection. Nature 397: 76-80.
28. Gadd MS, Bhati M, Jeffries CM, Langley DB, Trewhella J, et al. (2011) Structural basis for partial redundancy in a class of transcription factors, the LIM homeodomain proteins, in neural cell type specification. J Biol Chem 286: 42971-42980.
29. Parker GE, Sandoval RM, Feister HA, Bidwell JP, Rhodes SJ, (2000) The homeodomain coordinates nuclear entry of the Lhx3 neuroendocrine transcription factor and association with the nuclear matrix. J Biol Chem 275: 23891-23898.
30. Parker GE, West BE, Witzmann FA, Rhodes SJ, (2005) Serine/threonine/tyrosine phosphorylation of the LHX3 LIM-homeodomain transcription factor. J Cell Biochem 94: 67-80.
31. Sloop KW, Dwyer CJ, Rhodes SJ, (2001) An isoform-specific inhibitory domain regulates the LHX3 LIM homeodomain factor holoprotein and the production of a functional alternate translation form. J Biol Chem 276: 36311-36319.
32. Granger A, Bleux C, Kottler ML, Rhodes SJ, Counis R, et al. (2006) The LIM-homeodomain proteins Isl-1 and Lhx3 act with steroidogenic factor 1 to enhance gonadotrope-specific activity of the gonadotropin-releasing hormone receptor gene promoter. Mol Endocrinol 20: 2093-2108.
33. McGillivray SM, Bailey JS, Ramezani R, Kirkwood BJ, Mellon PL, (2005) Mouse GnRH receptor gene expression is mediated by the LHX3 homeodomain protein. Endocrinology 146: 2180-2185.
34. Sloop KW, Meier BC, Bridwell JL, Parker GE, Schiller AM, et al. (1999) Differential activation of pituitary hormone genes by human Lhx3 isoforms with distinct DNA binding properties. Mol Endocrinol 13: 2212-2225.
35. West BE, Parker GE, Savage JJ, Kiratipranon P, Toomey KS, et al. (2004) Regulation of the follicle-stimulating hormone beta gene by the LHX3 LIM-homeodomain transcription factor. Endocrinology 145: 4866-4879.
36. Bach I, Rodriguez-Esteban C, Carriere C, Bhushan A, Krones A, et al. (1999) RLIM inhibits functional activity of LIM homeodomain transcription factors via recruitment of the histone deacetylase complex. Nat Genet 22: 394-399.
37. Jurata LW, Kenny DA, Gill GN, (1996) Nuclear LIM interactor, a rhombotin and LIM homeodomain interacting protein, is expressed early in neuronal development. Proc Natl Acad Sci USA 93: 11693-11698.
38. Hashimoto K, Yamada M, Monden T, Satoh T, Wondisford FE, et al. (2005) Thyrotropin-releasing hormone (TRH) specific interaction between amino terminus of P-Lim and CREB binding protein (CBP). Mol Cell Endocrinol 229: 11-20.
39. Ostendorff HP, Peirano RI, Peters MA, Schluter A, Bossenz M, et al. (2002) Ubiquitination-dependent cofactor exchange on LIM homeodomain transcription factors. Nature 416: 99-103.
40. Seo S, McNamara P, Heo S, Turner A, Lane W, et al. (2001) Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein. Cell 104: 119-130.
41. Eitoku M, Sato L, Senda T, Horikoshi M, (2008) Histone chaperones: 30 years from isolation to elucidation of the mechanisms of nucleosome assembly and disassembly. Cell Mol Life Sci 65: 414-444.
42. Kim JY, Kim KB, Son HJ, Chae YC, Oh ST, et al. (2012) H3K27 methylation and H3S28 phosphorylation-dependent transcriptional regulation by INHAT subunit SET/TAF-Ibeta. FEBS Lett 586: 3159-3165.
43. Kim JY, Lee KS, Seol JE, Yu K, Chakravarti D, et al. (2012) Inhibition of p53 acetylation by INHAT subunit SET/TAF-Ibeta represses p53 activity. Nucleic Acids Res 40: 75-87.
44. Kato K, Okuwaki M, Nagata K, (2011) Role of Template Activating Factor-I as a chaperone in linker histone dynamics. J Cell Sci 124: 3254-3265.
45. Lee IS, Oh SM, Kim SM, Lee DS, Seo SB, (2006) Highly acidic C-terminal domain of pp32 is required for the interaction with histone chaperone, TAF-Ibeta. Biol Pharm Bull 29: 2395-2398.
46. Lew D, Brady H, Klausing K, Yaginuma K, Theill LE, et al. (1993) GHF-1-promoter-targeted immortalization of a somatotropic progenitor cell results in dwarfism in transgenic mice. Genes Dev 7: 683-693.
47. Alarid ET, Windle JJ, Whyte DB, Mellon PL, (1996) Immortalization of pituitary cells at discrete stages of development by directed oncogenesis in transgenic mice. Development 122: 3319-3329.
48. Roberson MS, Schoderbek WE, Tremml G, Maurer RA, (1994) Activation of the glycoprotein hormone alpha-subunit promoter by a LIM-homeodomain transcription factor. Mol Cell Biol 14: 2985-2993.
49. Meier BC, Price JR, Parker GE, Bridwell JL, Rhodes SJ, (1999) Characterization of the porcine Lhx3/LIM-3/P-Lim LIM homeodomain transcription factor. Mol Cell Endocrinol 147: 65-74.
50. Drolet DW, Scully KM, Simmons DM, Wegner M, Chu KT, et al. (1991) TEF, a transcription factor expressed specifically in the anterior pituitary during embryogenesis, defines a new class of leucine zipper proteins. Genes Dev 5: 1739-1753.
51. Matilla A, Koshy BT, Cummings CJ, Isobe T, Orr HT, et al. (1997) The cerebellar leucine-rich acidic nuclear protein interacts with ataxin-1. Nature 389: 974-978.
52. Li M, Makkinje A, Damuni Z, (1996) Molecular Identification of I1PP2A, a Novel Potent Heat-Stable Inhibitor Protein of Protein Phosphatase 2A†Biochemistry. 35: 6998-7002.
53. Seo S-b, Macfarlan T, McNamara P, Hong R, Mukai Y, et al. (2002) Regulation of Histone Acetylation and Transcription by Nuclear Protein pp32, a Subunit of the INHAT Complex. Journal of Biological Chemistry 277: 14005-14010.
54. Nagata K, Kawase H, Handa H, Yano K, Yamasaki M, et al. (1995) Replication factor encoded by a putative oncogene, set, associated with myeloid leukemogenesis. Proceedings of the National Academy of Sciences of the United States of America 92: 4279-4283.
55. Telese F, Bruni P, Donizetti A, Gianni D, D'Ambrosio C, et al. (2005) Transcription regulation by the adaptor protein Fe65 and the nucleosome assembly factor SET. EMBO Rep 6: 77-82.
56. Kutney SN, Hong R, Macfarlan T, Chakravarti D, (2004) A Signaling Role of Histone-binding Proteins and INHAT Subunits pp32 and Set/TAF-IÎ2 in Integrating Chromatin Hypoacetylation and Transcriptional Repression. Journal of Biological Chemistry 279: 30850-30855.
57. Schneider R, Bannister AJ, Weise C, Kouzarides T, (2004) Direct binding of INHAT to H3 tails disrupted by modifications. J Biol Chem 279: 23859-23862.
58. Hashimoto K, Yamada M, Monden T, Satoh T, Wondisford FE, et al. (2005) Thyrotropin-releasing Hormone (TRH) specific interaction between amino terminus of P-Lim and CREB binding protein (CBP). Molecular and Cellular Endocrinology 229: 11-20.
59. Karetsou Z, Martic G, Sflomos G, Papamarcaki T, (2005) The histone chaperone SET/TAF-Ibeta interacts functionally with the CREB-binding protein. Biochem Biophys Res Commun 335: 322-327.
60. Kular RK, Cvetanovic M, Siferd S, Kini AR, Opal P, (2009) Neuronal Differentiation Is Regulated by Leucine-rich Acidic Nuclear Protein (LANP), a Member of the Inhibitor of Histone Acetyltransferase Complex. Journal of Biological Chemistry 284: 7783-7792.
61. Matilla A, Radrizzani M, (2005) The Anp32 family of proteins containing leucine-rich repeats. Cerebellum 4: 7-18.
62. Estanyol J, Jaumot M, Casanovas O, Rodriguez-Vilarrupla A, Agell N, et al. (1999) The protein SET regulates the inhibitory effect of p21(Cip1) on cyclin E-cyclin-dependent kinase 2 activity. J Biol Chem 274: 33161-33165.
63. Kato K, Miyaji-Yamaguchi M, Okuwaki M, Nagata K, (2007) Histone acetylation-independent transcription stimulation by a histone chaperone. Nucleic Acids Res 35: 705-715.
64. Loven MA, Davis RE, Curtis CD, Muster N, Yates JR, et al. (2004) A Novel Estrogen Receptor {alpha}-Associated Protein Alters Receptor-Deoxyribonucleic Acid Interactions and Represses Receptor-Mediated Transcription. Mol Endocrinol 18: 2649-2659.
65. Loven MA, Muster N, Yates JR, Nardulli AM, (2003) A Novel Estrogen Receptor {alpha}-Associated Protein, Template-Activating Factor I{beta}, Inhibits Acetylation and Transactivation. Mol Endocrinol 17: 67-78.
66. Ichijo T, Chrousos G, Kino T, (2008) Activated glucocorticoid receptor interacts with the INHAT component Set/TAF-Ibeta and releases it from a glucocorticoid-responsive gene promoter, relieving repression: implications for the pathogenesis of glucocorticoid resistance in acute undifferentiated leukemia with Set-Can translocation. Mol Cel Endocrinol 283: 19-31.
67. Macfarlan T, Parker JB, Nagata K, Chakravarti D, (2006) Thanatos-Associated Protein 7 Associates with Template Activating Factor-I{beta} and Inhibits Histone Acetylation to Repress Transcription. Mol Endocrinol 20: 335-347.
68. Trivedi CM, Zhu W, Wang Q, Jia C, Kee HJ, et al. (2010) Hopx and Hdac2 Interact to Modulate Gata4 Acetylation and Embryonic Cardiac Myocyte Proliferation. Developmental Cell 19: 450-459.